External Traditional Chinese Medicine Therapies for Chronic Musculoskeletal and Soft-Tissue Pain

Abstract

Chronic musculoskeletal and soft-tissue pain poses enduring clinical challenges, prompting growing interest in external Traditional Chinese Medicine (TCM) modalities, principally acupuncture, tuina, and moxibustion. Recent multicenter observational trials and assessor-blinded protocols suggest that integrative regimens may modulate nociceptive sensitization, restore local tissue compliance, and alleviate pain-related affective distress to some extent. However, establishing definitive causal pathways remains complicated by pervasive methodological heterogeneity, including the subtle biomechanical variations inherent in manual techniques, inconsistent sham-control validity, and variable diagnostic standards regarding meridian and tendon differentiation. While altered inflammatory biomarkers and elevated pressure pain thresholds provide plausible neurobiological indicators, these shifts might also reflect systemic neuro-endocrine-immune recalibration or contextual therapeutic engagement rather than isolated meridional effects. Considering these interpretive nuances, conventional single-endpoint evaluations appear somewhat inadequate for capturing the holistic "body-mind" therapeutic continuum. Rather than treating external TCM procedures as purely empirical physical interventions, future research should integrate standardized operator training with high-resolution objective phenotyping and longitudinal tracking. Advancing this integrative paradigm requires cautious deconstruction of treatment artifacts, thereby situating traditional somatic therapies within contemporary neurobiological frameworks without diluting their individualized holistic foundations.